Laboratory testing

Ended Purchase Order Awarded Last action

Contract number
75N91023P00720
Awardee
Awarding agency
Obligated
$23,520

Award facts

Contract value 100% obligated
$23,520.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02134, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National Cancer Institute's research efforts to better understand disease mechanisms and develop new treatment strategies in the fight against cancer.

Quick answers

Who was awarded contract 75N91023P00720?

75N91023P00720 was awarded to Human Metabolome Technologies America, Inc. by National Cancer Institute (National Institutes of Health) on August 22, 2023.

How much is contract 75N91023P00720 worth?

The government has obligated $23,520 on 75N91023P00720.

Was contract 75N91023P00720 competed?

The extent of competition for 75N91023P00720 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login